Growth Metrics

Standard Biotools (LAB) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn -32.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -32.77%
Dec 31, 2025 138.73%
Sep 30, 2025 11.49%
Jun 30, 2025 44.97%
Mar 31, 2025 44.14%
Dec 31, 2024 -32.10%
Sep 30, 2024 -111.79%
Jun 30, 2024 -303.14%
Mar 31, 2024 -566.21%
Dec 31, 2023 43.28%
Sep 30, 2023 52.40%
Jun 30, 2023 67.12%
Mar 31, 2023 42.31%
Dec 31, 2022 -3,887.20%
Sep 30, 2022 48.10%
Jun 30, 2022 20.01%
Mar 31, 2022 16.98%
Dec 31, 2021 96.54%
Sep 30, 2021 -909.72%
Jun 30, 2021 -1,026.79%
Mar 31, 2021 -272.28%
Dec 31, 2020 -139.91%
Sep 30, 2020 16.22%
Jun 30, 2020 36.84%
Mar 31, 2020 73.89%
Dec 31, 2019 -814.74%
Sep 30, 2019 -38.29%
Jun 30, 2019 -23.45%
Mar 31, 2019 -25.49%
Dec 31, 2018 -236.23%
Sep 30, 2018 50.06%
Jun 30, 2018 47.82%
Mar 31, 2018 -77.05%
Dec 31, 2017 104.23%
Sep 30, 2017 42.99%
Jun 30, 2017 4.96%
Mar 31, 2017 -2.73%
Dec 31, 2016 -95.58%
Sep 30, 2016 -15.74%
Jun 30, 2016 3.88%
Mar 31, 2016 16.56%
Dec 31, 2015 -16.61%
Sep 30, 2015 -26.58%
Jun 30, 2015 -278.59%
Mar 31, 2015 13.36%
Dec 31, 2014 -469.12%
Sep 30, 2014 -421.11%
Jun 30, 2014 14.49%
Mar 31, 2014 -681.29%
Dec 31, 2013 131.84%
Sep 30, 2013 47.26%
Jun 30, 2013 41.12%
Mar 31, 2013 77.53%
Dec 31, 2012 -45.26%
Sep 30, 2012 -39.67%
Jun 30, 2012 60.22%
Mar 31, 2012 -385.85%
Dec 31, 2011 -9.89%
Sep 30, 2011 27.90%